At The DNA Company, CEO Tracy Wood connects genetic data with scientific review, education, coaching and clinician support. The aim: help clients and practitioners understand what a report means for one person.
What can DNA tell one person about how their body functions?
The DNA Company built its functional-genomics business around that question. The newly launched DNA360 genetic kit scans 4.7 billion data points from a saliva sample. But testing is only the entry point.
The company pairs its reports with scientific review, education for clients and practitioners, coaching, clinician consultations and digital access.
The scientific team groups related genetic findings by how biological systems work together. Trained practitioners interpret those reports alongside a client’s health history, environment and laboratory results.
The Question That Started The Dna Company
The DNA Company began in Canada in 2016. Other DNA tests already reported ancestry and disease-risk information. The company set out to learn what DNA might reveal about how each person functions.
“What if our DNA could tell us more than what diseases we might get or where our ancestors came from? What if it could actually help us understand how we function?” Tracy Wood, CEO of The DNA Company, asks.
The company uses functional genomics to examine how genetic variants relate to the way a person functions. Its systems-biology method brings together findings connected to the same biological processes instead of reading one variant as an isolated instruction.
The reports cover nutrient and hormone metabolism, inflammatory response, energy production, stress and gut functions, and cellular maintenance and repair.
“Your genes are not diagnostic in a vacuum. They are not fatalistic,” Wood says.
The DNA Company places each genetic finding within a wider health picture. A result may point to a tendency or help frame a question. That context gives clients more focused questions to explore with qualified practitioners.
A Merger Brings Genetics Into a Wider Health Model
Before entering healthcare, Tracy Wood founded two telecommunications companies and led both through successful exits. She moved into telemedicine and health technology in 2009.
In 2016, she joined the leadership team of ROLA HealthShare. ROLA focused on prevention, education, lifestyle medicine and access to care. It called that philosophy Reverse and Prevent.
The DNA Company’s functional-genomics work added a genetics layer to the preventive health model Wood had pursued at ROLA. The businesses merged in 2022, triggering The DNA Company’s move to California.
Wood became chief operating officer in January 2023. She helped develop a mobile primary-care and virtual-clinic strategy, a concierge model and a precision-health approach.
The DNA Company credits Wood with leading the business to its first profitable year. She reshaped the technology stack, rebuilt the public interface and became CEO in July 2023.
Education Solves The Other Half of The Problem
As the reports became more sophisticated, Wood realized practitioners needed deeper training to interpret them.
“If nobody knows how to properly interpret it, you’ve solved only half the problem,” Wood says.
These reports gave practitioners a new task: understanding how multiple genetic findings relate across biological pathways. Wood founded DNA University in 2023 to teach practitioners how the company’s scientists organize those findings and explain their connections.
DNA University’s programs cover functional genomics, genetics, epigenetics and precision wellness. The training gives practitioners tools to connect findings, ask better questions, explain reports to clients and place genetic information in context.
Clients and members of the public can attend the company’s webinars. Topics include genetics, wellness, personalized medicine, mental health, inflammation and fasting. The company also produces workshops, podcasts and articles.
Scientists Keep Human Judgment in The System
Dr. Krista Kostroman leads the company’s science and research. Her background spans functional genomics, naturopathic medicine and computer science.
Her team translates complex genetic data into explanations for practitioners and clients. The scientific team bases its interpretations on peer-reviewed scientific and clinical literature.
The company uses artificial intelligence to find, organize and explain information. Scientists review each interpretation and remain responsible for it.
“Confident and correct are not the same thing,” Wood says.
Four Tests Cover Three Areas of Biology
The DNA Company’s four tests cover inherited genetics, biological aging and the gut microbiome.
- DNA180 provides foundational functional-genomics reports on nutrition, hormones, sleep and longevity.
- The company released DNA360 in July 2026. It organizes genetic associations across connected pathways involving metabolism, inflammation, energy, hormone processing and cellular repair.
- DNAging examines epigenetic markers to estimate biological age.
- DNA Gut360 analyzes the gut microbiome, the community of microorganisms living in the digestive tract.
The company continues developing its reports. It says DNA360 reports can receive new insights as research advances.
Clients Control Access to Their Genetic Reports
Clients can view their reports through personal accounts in the company’s secure online portal or The DNA Way app. They may also add coaching or a clinician consultation.
Clients can authorize a practitioner to review their reports. The company requires that permission before granting access. It says it does not sell clients’ identifiable personal or genetic data.
Once authorized, trained practitioners interpret the findings alongside a client’s health history, laboratory results and environment. They explain what the report suggests and help the client frame questions for further review.
One More Life Gives The Business Its Direction
Tracy Wood’s ambition extends beyond testing. She wants functional genomics to help move healthcare toward prevention and a deeper understanding of the individual.
That ambition comes from personal experience. In 2007, Wood’s sister, Jackie Whittet, died unexpectedly after taking a combination of prescribed medications.
The loss redirected Wood into healthcare and left her asking, “What can I do right now to change this for the next person?” She later founded Hera Nurture, a nonprofit that supports women facing financial hardship.
Wood calls the mission One More Life. At The DNA Company, functional genomics serves that mission. It helps one more practitioner to ask better questions. It helps one more person to understand their own biology.
Disclaimer
DNA360 is intended for educational and informational purposes only and is not intended to diagnose, treat, cure, prevent, or mitigate any disease or medical condition. Genetic insights provided by DNA360 should not be used as a substitute for professional medical advice, diagnosis, or treatment. Individuals should consult with qualified healthcare professionals regarding any healthcare decisions.
